Tobacco spending and related controlled substance transactions represent a discretionary expense allocation and potential health risk proxy that, when material relative to income, reduces effective repayment capacity in ways that FOIR from EMI obligations alone does not capture.
Match transaction descriptions against cigarette and tobacco brand names, retail outlet names associated with tobacco products, hookah lounge names, and terms associated with controlled substance procurement through non-pharmaceutical channels. Explicitly exclude licensed pharmacy names to prevent false-positive flagging of legitimate healthcare spending.
Enable for NBFC and HFC underwriting. Maintain pharmacy whitelist to prevent healthcare misclassification. Review alongside alcohol and gambling signals for complete vice spending aggregate. Set income-share threshold based on lender policy.
Tobacco and controlled substance risk section in the credit report with transaction count, total debit, top five matched terms, and aggregate discretionary allocation across vice spending categories.
The tobacco and controlled substance category in bank statement risk analysis is often the most straightforward of the ten risk word categories to explain: it covers spending on tobacco products and, separately, transactions that indicate controlled substance procurement through non-pharmaceutical channels. The two are distinct — legal tobacco products and pharmacy prescriptions sit on one side; unlicensed procurement patterns sit on the other.
This is a credit risk data point, not a moral assessment.
What the Category Covers
The tobacco component covers detectable spending on tobacco products across India’s distribution channels: branded cigarettes sold through retail, regional tobacco and beedi brands, pan masala and chewing tobacco, hookah lounges, and premium cigar retailers. These transactions appear in bank statements via card swipes at retail outlets, UPI payments to tobacco retailers, and point-of-sale entries at hospitality venues where the primary service includes hookah or tobacco.
The controlled substance component is a narrower and more sensitive detection category. It does not target prescription medicines or pharmacy purchases — those are classified under healthcare spending. It targets narration patterns associated with procurement through non-licensed channels, where the transaction description or counterparty is inconsistent with regulated pharmaceutical or retail supply. This distinction is operationally important: a borrower who regularly purchases medication at Apollo Pharmacy or 1mg is showing healthcare spending, not a controlled substance signal.
The combined category produces a spending aggregate that complements the alcohol, gambling, and luxury detection modules — giving the credit officer a complete view of discretionary spending that may reduce effective repayment capacity.
How Tobacco Transactions Appear in Indian Bank Statements
Indian tobacco spending disperses across several transaction types, making it one of the harder discretionary categories to capture comprehensively at low transaction values.
Branded retail transactions at shops that stock primarily tobacco products appear via UPI payments where the shop name includes the tobacco brand or a recognisable retail naming pattern. In many cases, the merchant name in the bank narration reflects the shop’s UPI ID registered name rather than the brand.
Point-of-sale card transactions at tobacco retail and pan shops appear as small-value card swipes. Below ₹200, many Indian consumers use UPI exclusively — meaning small tobacco purchases are increasingly visible in bank statements through UPI narrations.
Hookah lounges and speciality tobacco retailers appear as restaurant or entertainment point-of-sale entries. Premium establishments appear by name; smaller outlets may appear with generic merchant codes.
Premium tobacco (imported cigarettes, premium cigars) appears via international card transactions at duty-free retailers or via e-commerce platforms that ship internationally.
Tobacco Category Risk Reference
| Transaction Type | Recognition Approach | Income Allocation Signal | Credit Context |
|---|---|---|---|
| Branded cigarette retail | Brand name + retail outlet pattern matching | Low to moderate per transaction; aggregate matters | Assess as total monthly allocation vs income |
| Beedi / regional tobacco | Regional brand names + wholesale outlet patterns | Low per transaction | Relevant in aggregate for income-scarce borrowers |
| Hookah lounge spending | Venue name matching; hospitality classification | Moderate — leisure spending; combine with alcohol signal | Review alongside total entertainment spending |
| Premium / imported tobacco | International card debit; duty-free transaction | High income-relative signal if inconsistent with income | Lifestyle-income consistency check |
| Controlled substance (non-pharmaceutical) | Non-pharmacy counterparty pattern matching | Separate category — not income allocation | Legal and compliance review |
India-Specific Context
India’s tobacco retail structure is dominated by small unorganised retailers — pan shops, beedi shops, and general stores. Most transactions at these outlets are UPI payments at amounts typically between ₹20 and ₹300. At these values, individual transactions are rarely material. The credit signal lies in the aggregate pattern: a borrower making 3 to 5 small tobacco-related UPI payments daily over 12 months is showing a consistent discretionary expense that adds up to several thousand rupees per month.
The legal framework for tobacco in India — governed by the Cigarettes and Other Tobacco Products Act (COTPA) 2003 and the National Tobacco Control Programme — does not restrict purchase or possession of tobacco products by adults. The credit risk use of this category therefore does not rely on legal restriction. It relies on income allocation analysis: how much of the applicant’s income is committed to tobacco and related spending, and what does that imply for repayment capacity alongside other obligations.
The Ministry of Finance, Government of India oversees PMLA and the regulatory framework for digital lending. For the controlled substance component of this category, PMLA obligations may be relevant when transactions indicate procurement through unlicensed channels — a compliance review point separate from the credit decision.
The bank statement risk word analysis covers tobacco brand names, retail outlet patterns, and controlled substance indicators, with licensed pharmacy names explicitly excluded to prevent misclassification of healthcare spending.
The bank statement analysis platform presents tobacco spending alongside alcohol, gambling, and luxury categories in a single discretionary spend section — so the credit officer sees the aggregate allocation across all discretionary categories rather than reviewing each in isolation.